| Literature DB >> 25222572 |
Matthieu Sanchez, Marion Delpont, Manon Bachy, Reda Kabbaj, Daniel Annequin, Raphaël Vialle.
Abstract
BACKGROUND: Multiple distraction strategies have been proposed to reduce the incidence of anxiety and pain in children. Animal-assisted therapy is acknowledged and used in children as an adjunctive treatment with cognitive, physical, psychosocial and spiritual benefits.Entities:
Mesh:
Year: 2014 PMID: 25222572 PMCID: PMC4325897 DOI: 10.1155/2015/419412
Source DB: PubMed Journal: Pain Res Manag ISSN: 1203-6765 Impact factor: 3.037
Figure 1)Pictures of the marine aquarium used for subjects’ distraction. A The 265-gallon (approximately 1000 L) saltwater aquarium was located in the department’s main waiting room. Live population included >20 species of soft and hard corals and >25 fish with a specific lighting system that mimicked natural reef lighting at a depth of 5 m. B Children and parents are invited to watch the aquarium
Figure 2)The Pain Matcher (Cefar Medical AB, Sweden) is an instrument for electrical stimulation that provides constant current stimulation despite variable skin resistance. The electrical charge per second is extremely low and causes no tissue damage. The intensity value (0 to 99) is directly related to the pulse width and is displayed on a liquid crystal screen
Pain Matcher[*] threshold values in both groups
|
|
| |||||
|---|---|---|---|---|---|---|
| First noticeable sensation | Before exposure | 4.07 | 2–8 | 0 | 4.07 | 3–8 |
| 5 min | 4.03 | 2–7 | 5 | 3.86 | 3–5 | |
| 10 min | 4.03 | 2–9 | 10 | 4.07 | 3–5 | |
| 20 min | 4.04 | 2–7 | 20 | 4.07 | 3–5 | |
| 30 min | 4.22 | 2–8 | 30 | 3.93 | 2–7 | |
| 10 min after the end of exposure | 4.20 | 2–10 | 40 | 4.21 | 3–5 | |
| Pain threshold | Before exposure | 16.03 | 3–63 | 0 | 18.43 | 8–68 |
| 5 min | 19.67 | 3–82 | 5 | 17.57 | 10–34 | |
| 10 min | 22.16 | 3–100 | 10 | 17.64 | 9–42 | |
| 20 min | 21.88 | 3–100 | 20 | 21.79 | 11–86 | |
| 30 min | 25.20 | 3–100 | 30 | 22.21 | 9–86 | |
| 10 min after the end of exposure | 24.58 | 4–100 | 40 | 23.71 | 10–99 | |
Cefar Medical AB, Sweden
Statistical analysis regarding Pain Matcher[*] threshold values in both groups
|
|
| |||||
|---|---|---|---|---|---|---|
| First noticeable sensation | Before exposure – 5 min | 0.455 | 0.651 | 0 min – 5 min | −0.551 | 0.582 |
| Before exposure – 10 min | 0.323 | 0.747 | 0 min – 10 min | −0.905 | 0.366 | |
| Before exposure – 20 min | 0.234 | 0.816 | 0 min – 20 min | −0.367 | 0.713 | |
| Before exposure – 30 min | −0.971 | 0.335 | 0 min – 30 min | −0.155 | 0.877 | |
| Before exposure – 10 min after the end of exposure | −0.809 | 0.421 | 0 min – 40 min | −0.734 | 0.463 | |
|
| ||||||
| Pain threshold (Wilcoxon signed ranks test) | Before exposure – 5 min | −5.11 | < 0.0001 | 0 min – 5 min | −1.268 | 0.205 |
| Before exposure – 10 min | −5.98 | < 0.0001 | 0 min – 10 min | −0.805 | 0.404 | |
| Before exposure – 20 min | −5.79 | < 0.0001 | 0 min – 20 min | −0.876 | 0.381 | |
| Before exposure – 30 min | −6.28 | < 0.0001 | 0 min – 30 min | −1.379 | 0.168 | |
| Before exposure – 10 min after the end of exposure | −6.13 | < 0.0001 | 0 min – 40 min | −0.035 | 0.972 | |
Cefar Medical AB, Sweden
Figure 3)Graphic representation of cumulative values of sensation and pain threshold measurements at different times of the protocol
Pain Matcher[*] threshold values in male (n=29) and female (n=40) subjects exposed to the aquarium
| First noticeable sensation | Before exposure | M | 4.17±1.31 | 0.63 | 0.53 |
| F | 4.00±0.96 | ||||
| 5 min | M | 4.28±1.33 | 1.55 | 0.13 | |
| F | 3.85±0.95 | ||||
| 10 min | M | 4.24±1.50 | 1.20 | 0.24 | |
| F | 3.88±1.04 | ||||
| 20 min | M | 4.24±1.09 | 1.26 | 0.21 | |
| F | 3.90±1.13 | ||||
| 30 min | M | 4.38±1.18 | 0.90 | 0.37 | |
| F | 4.10±1.34 | ||||
| 10 min after the end of exposure | M | 4.34±1.14 | 0.77 | 0.44 | |
| F | 4.10±1.41 | ||||
| Pain threshold | Before exposure | M | 22.28±13.29 | 4.61 | <0.0001 |
| F | 11.50±5.60 | ||||
| 5 min | M | 27.28±16.94 | 4.31 | <0.0001 | |
| F | 14.15±7.85 | ||||
| 10 min | M | 31.69±21.71 | 4.36 | <0.0001 | |
| F | 15.25±8.48 | ||||
| 20 min | M | 28.59±18.65 | 3.33 | 0.001 | |
| F | 17.03±9.96 | ||||
| 30 min | M | 34.83±22.96 | 4.03 | <0.0001 | |
| F | 18.23±10.59 | ||||
| 10 min after the end of exposure | M | 34.48±26.11 | 3.62 | 0.001 | |
| F | 17.40±12.36 |
Cefar Medical AB, Sweden. F Female; M Male